Natural cannabinoid found to play key role in anxiety

Stress-related mood and anxiety disorders affect millions of people in the United States. A new study examines the neurobiology behind these illnesses and finds that controlling a molecule that activates cannabinoid receptors can reduce the symptoms of anxiety.

Endocannabinoids help the brain to adapt to stress, and new research shows that the 2-arachidonoylglycerol endocannabinoid plays a key role in anxiety.

More than 40 million U.S. adults (or 18 percent of the entire population) live with anxiety disorders, including clinical depression, panic disorders, phobias, and post-traumatic stress disorder (PTSD).

Generalized anxiety disorder affects almost 7 million of these adults, and more at